{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26339628", "DateCompleted": {"Year": "2016", "Month": "05", "Day": "19"}, "DateRevised": {"Year": "2020", "Month": "03", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "08", "Day": "03"}], "ELocationID": ["657159", "10.1155/2015/657159"], "Language": ["eng"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2015", "PubDate": {"Year": "2015"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Screening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation.", "Pagination": {"StartPage": "657159", "MedlinePgn": "657159"}, "Abstract": {"AbstractText": ["The issue of herb-drug interactions has been widely reported. Herbal ingredients can activate nuclear receptors and further induce the gene expression alteration of drug-metabolizing enzyme and/or transporter. Therefore, the herb-drug interaction will happen when the herbs and drugs are coadministered. This kind of interaction is called inductive herb-drug interactions. Pregnane X Receptor (PXR) and drug-metabolizing target genes are involved in most of inductive herb-drug interactions. To predict this kind of herb-drug interaction, the protocol could be simplified to only screen agonists of PXR from herbs because the relations of drugs with their metabolizing enzymes are well studied. Here, a combinational in silico strategy of pharmacophore modelling and docking-based rank aggregation (DRA) was employed to identify PXR's agonists. Firstly, 305 ingredients were screened out from 820 ingredients as candidate agonists of PXR with our pharmacophore model. Secondly, DRA was used to rerank the result of pharmacophore filtering. To validate our prediction, a curated herb-drug interaction database was built, which recorded 380 herb-drug interactions. Finally, among the top 10 herb ingredients from the ranking list, 6 ingredients were reported to involve in herb-drug interactions. The accuracy of our method is higher than other traditional methods. The strategy could be extended to studies on other inductive herb-drug interactions."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China."}], "LastName": "Cui", "ForeName": "Zhijie", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China."}], "LastName": "Kang", "ForeName": "Hong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China."}], "LastName": "Tang", "ForeName": "Kailin", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China."}], "LastName": "Liu", "ForeName": "Qi", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China ; Shanghai Center for Bioinformation Technology, Shanghai, China."}], "LastName": "Cao", "ForeName": "Zhiwei", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Bioinformatics, Tongji University, Shanghai 200092, China ; School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, Liaoning, China."}], "LastName": "Zhu", "ForeName": "Ruixin", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Pregnane X Receptor"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Steroid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "Databases, Factual"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": ["genetics"], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Inactivation, Metabolic"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Pregnane X Receptor"}, {"QualifierName": ["agonists", "chemistry", "genetics"], "DescriptorName": "Receptors, Steroid"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tachjian A., Maria V., Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. Journal of the American College of Cardiology. 2010;55(6):515\u2013525. doi: 10.1016/j.jacc.2009.07.074.", "ArticleIdList": ["10.1016/j.jacc.2009.07.074", "PMC2831618", "20152556"]}, {"Citation": "Kaufman D. W., Kelly J. P., Rosenberg L., Anderson T. E., Mitchell A. A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. The Journal of the American Medical Association. 2002;287(3):337\u2013344. doi: 10.1001/jama.287.3.337.", "ArticleIdList": ["10.1001/jama.287.3.337", "11790213"]}, {"Citation": "Bush T. M., Rayburn K. S., Holloway S. W., et al. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. Alternative Therapies in Health and Medicine. 2007;13(2):30\u201335.", "ArticleIdList": ["17405676"]}, {"Citation": "Palleria C., Di Paolo A., Giofre C., et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. Journal of Research in Medical Sciences. 2013;18(7):601\u2013610.", "ArticleIdList": ["PMC3897029", "24516494"]}, {"Citation": "Jonker D. M., Visser S. A. G., van der Graaf P. H., Voskuyl R. A., Danhof M. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacology & Therapeutics. 2005;106(1):1\u201318. doi: 10.1016/j.pharmthera.2004.10.014.", "ArticleIdList": ["10.1016/j.pharmthera.2004.10.014", "15781119"]}, {"Citation": "Bi X., Gong M., Di L. Review on prescription compatibility of shaoyao gancao decoction and reflection on pharmacokinetic compatibility mechanism of traditional chinese medicine prescription based on in vivo drug interaction of main efficacious components. Evidence-Based Complementary and Alternative Medicine. 2014;2014 doi: 10.1155/2014/208129.208129", "ArticleIdList": ["10.1155/2014/208129", "PMC4132488", "25147573"]}, {"Citation": "Lehmann J. M., McKee D. D., Watson M. A., Willson T. M., Moore J. T., Kliewer S. A. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. The Journal of Clinical Investigation. 1998;102(5):1016\u20131023. doi: 10.1172/jci3703.", "ArticleIdList": ["10.1172/jci3703", "PMC508967", "9727070"]}, {"Citation": "Baes M., Gulick T., Choi H.-S., Martinolu M. G., Simha D., Moore D. D. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Molecular and Cellular Biology. 1994;14(3):1544\u20131552.", "ArticleIdList": ["PMC358513", "8114692"]}, {"Citation": "Makishima M., Lu T. T., Xie W., et al. Vitamin D receptor as an intestinal bile acid sensor. Science. 2002;296(5571):1313\u20131316. doi: 10.1126/science.1070477.", "ArticleIdList": ["10.1126/science.1070477", "12016314"]}, {"Citation": "Harmsen S., Meijerman I., Beijnen J. H., Schellens J. H. M. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treatment Reviews. 2007;33(4):369\u2013380. doi: 10.1016/j.ctrv.2007.02.003.", "ArticleIdList": ["10.1016/j.ctrv.2007.02.003", "17451886"]}, {"Citation": "Abernethy D. R., Flockhart D. A. Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions. Circulation. 2000;101(14):1749\u20131753. doi: 10.1161/01.cir.101.14.1749.", "ArticleIdList": ["10.1161/01.cir.101.14.1749", "10758060"]}, {"Citation": "Staudinger J. L., Ding X., Lichti K. Pregnane X receptor and natural products: beyond drug-drug interactions. Expert Opinion on Drug Metabolism & Toxicology. 2006;2(6):847\u2013857. doi: 10.1517/17425255.2.6.847.", "ArticleIdList": ["10.1517/17425255.2.6.847", "PMC2978027", "17125405"]}, {"Citation": "Chang T. K. H., Waxman D. J. Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR) Drug Metabolism Reviews. 2006;38(1-2):51\u201373. doi: 10.1080/03602530600569828.", "ArticleIdList": ["10.1080/03602530600569828", "16684648"]}, {"Citation": "Cao W., Zhao A.-G. Prescription rules of Chinese herbal medicines in treatment of gastric cancer. Zhong Xi Yi Jie He Xue Bao. 2009;7(1):1\u20138. doi: 10.3736/jcim20090101.", "ArticleIdList": ["10.3736/jcim20090101", "19134451"]}, {"Citation": "Scheer N., Ross J., Rode A., et al. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. The Journal of Clinical Investigation. 2008;118(9):3228\u20133239. doi: 10.1172/jci35483.", "ArticleIdList": ["10.1172/jci35483", "PMC2493444", "18677425"]}, {"Citation": "Mills J. B., Rose K. A., Sadagopan N., Sahi J., de Morais S. M. F. Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. Journal of Pharmacology and Experimental Therapeutics. 2004;309(1):303\u2013309. doi: 10.1124/jpet.103.061713.", "ArticleIdList": ["10.1124/jpet.103.061713", "14722322"]}, {"Citation": "Goodwin B., Hodgson E., Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Molecular Pharmacology. 1999;56(6):1329\u20131339.", "ArticleIdList": ["10570062"]}, {"Citation": "Khandelwal A., Krasowski M. D., Reschly E. J., Sinz M. W., Swaan P. W., Ekins S. Machine learning methods and docking for predicting human pregnane X receptor activation. Chemical Research in Toxicology. 2008;21(7):1457\u20131467. doi: 10.1021/tx800102e.", "ArticleIdList": ["10.1021/tx800102e", "PMC2574557", "18547065"]}, {"Citation": "Kortagere S., Chekmarev D., Welsh W. J., Ekins S. Hybrid scoring and classification approaches to predict human pregnane X receptor activators. Pharmaceutical Research. 2009;26(4):1001\u20131011. doi: 10.1007/s11095-008-9809-7.", "ArticleIdList": ["10.1007/s11095-008-9809-7", "PMC2836910", "19115096"]}, {"Citation": "Kortagere S., Krasowski M. D., Reschly E. J., Venkatesh M., Mani S., Ekins S. Evaluation of computational docking to identify pregnane X receptor agonists in the ToxCast database. Environmental Health Perspectives. 2010;118(10):1412\u20131417. doi: 10.1289/ehp.1001930.", "ArticleIdList": ["10.1289/ehp.1001930", "PMC2957921", "20558333"]}, {"Citation": "Dybdahl M., Nikolov N. G., Wedebye E. B., J\u00f3nsd\u00f3ttir S. O., Niemel\u00e4 J. R. QSAR model for human pregnane X receptor (PXR) binding: screening of environmental chemicals and correlations with genotoxicity, endocrine disruption and teratogenicity. Toxicology and Applied Pharmacology. 2012;262(3):301\u2013309. doi: 10.1016/j.taap.2012.05.008.", "ArticleIdList": ["10.1016/j.taap.2012.05.008", "22627063"]}, {"Citation": "Jacobs M. N. In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology. 2004;205(1-2):43\u201353. doi: 10.1016/j.tox.2004.06.036.", "ArticleIdList": ["10.1016/j.tox.2004.06.036", "15458789"]}, {"Citation": "Ung C. Y., Li H., Yap C. W., Chen Y. Z. In silico prediction of pregnane X receptor activators by machine learning approaches. Molecular Pharmacology. 2007;71(1):158\u2013168. doi: 10.1124/mol.106.027623.", "ArticleIdList": ["10.1124/mol.106.027623", "17003167"]}, {"Citation": "Ekins S., Erickson J. A. A pharmacophore for human pregnane X receptor ligands. Drug Metabolism and Disposition. 2002;30(1):96\u201399. doi: 10.1124/dmd.30.1.96.", "ArticleIdList": ["10.1124/dmd.30.1.96", "11744617"]}, {"Citation": "Lemaire G., Benod C., Nahoum V., et al. Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore modeling and virtual screening to \u2018in vivo\u2019 biological activity. Molecular Pharmacology. 2007;72(3):572\u2013581. doi: 10.1124/mol.106.033415.", "ArticleIdList": ["10.1124/mol.106.033415", "17573484"]}, {"Citation": "Watkins R. E., Wisely G. B., Moore L. B., et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 2001;292(5525):2329\u20132333. doi: 10.1126/science.1060762.", "ArticleIdList": ["10.1126/science.1060762", "11408620"]}, {"Citation": "Moore L. B., Parks D. J., Jones S. A., et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. The Journal of Biological Chemistry. 2000;275(20):15122\u201315127. doi: 10.1074/jbc.m001215200.", "ArticleIdList": ["10.1074/jbc.m001215200", "10748001"]}, {"Citation": "Rose P. W., Prlic A., Bi C., et al. The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Research. 2014 doi: 10.1093/nar/gku1214.", "ArticleIdList": ["10.1093/nar/gku1214", "PMC4383988", "25428375"]}, {"Citation": "Watkins R. E., Davis-Searles P. R., Lambert M. H., Redinbo M. R. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. Journal of Molecular Biology. 2003;331(4):815\u2013828. doi: 10.1016/S0022-2836(03)00795-2.", "ArticleIdList": ["10.1016/S0022-2836(03)00795-2", "12909012"]}, {"Citation": "Wang W., Prosise W. W., Chen J., et al. Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability. Protein Engineering, Design and Selection. 2008;21(7):425\u2013433. doi: 10.1093/protein/gzn017.", "ArticleIdList": ["10.1093/protein/gzn017", "18456871"]}, {"Citation": "Liu T., Lin Y., Wen X., Jorissen R. N., Gilson M. K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research. 2007;35(supplement 1):D198\u2013D201. doi: 10.1093/nar/gkl999.", "ArticleIdList": ["10.1093/nar/gkl999", "PMC1751547", "17145705"]}, {"Citation": "Bickel S., Scheffer T. Multi-view clustering. Proceedings of the IEEE Data Mining Conference; November 2004; Brighton, UK. pp. 19\u201326."}, {"Citation": "Pihur V., Datta S. RankAggreg, an R package for weighted rank aggregation. BMC Bioinformatics. 2009;10, article 62 doi: 10.1186/1471-2105-10-62.", "ArticleIdList": ["10.1186/1471-2105-10-62", "PMC2669484", "19228411"]}, {"Citation": "Fagin R., Berbescu E., Landis S., Strumpf K., Patil U. Juvenile granulosa cell tumor of the testis. Urology. 2003;62(2):p. 351.", "ArticleIdList": ["12893354"]}, {"Citation": "Pihur V., Datta S., Datta S. Weighted rank aggregation of cluster validation measures: a Monte Carlo cross-entropy approach. Bioinformatics. 2007;23(13):1607\u20131615. doi: 10.1093/bioinformatics/btm158.", "ArticleIdList": ["10.1093/bioinformatics/btm158", "17483500"]}, {"Citation": "Raychaudhuri S., Jain V., Dongre M. Identification of a constitutively active variant of LuxO that affects production of HA/protease and biofilm development in a non-O1, non-O139 Vibrio cholerae O110. Gene. 2006;369(1-2):126\u2013133. doi: 10.1016/j.gene.2005.10.031.", "ArticleIdList": ["10.1016/j.gene.2005.10.031", "16376028"]}, {"Citation": "Butler K. T., Luque F. J., Barril X. Toward accurate relative energy predictions of the bioactive conformation of drugs. Journal of Computational Chemistry. 2009;30(4):601\u2013610. doi: 10.1002/jcc.21087.", "ArticleIdList": ["10.1002/jcc.21087", "18711721"]}, {"Citation": "Zhu R., Hu L., Li H., Su J., Cao Z., Zhang W. Novel natural inhibitors of CYP1A2 identified by in silico and in vitro screening. International Journal of Molecular Sciences. 2011;12(5):3250\u20133262. doi: 10.3390/ijms12053250.", "ArticleIdList": ["10.3390/ijms12053250", "PMC3116189", "21686183"]}, {"Citation": "Ferrara P., Gohlke H., Price D. J., Klebe G., Brooks C. L., III Assessing scoring functions for protein-ligand interactions. Journal of Medicinal Chemistry. 2004;47(12):3032\u20133047. doi: 10.1021/jm030489h.", "ArticleIdList": ["10.1021/jm030489h", "15163185"]}, {"Citation": "Warren G. L., Andrews C. W., Capelli A.-M., et al. A critical assessment of docking programs and scoring functions. Journal of Medicinal Chemistry. 2006;49(20):5912\u20135931. doi: 10.1021/jm050362n.", "ArticleIdList": ["10.1021/jm050362n", "17004707"]}, {"Citation": "Kang H., Sheng Z., Zhu R., Huang Q., Liu Q., Cao Z. Virtual drug screen schema based on multiview similarity integration and ranking aggregation. Journal of Chemical Information and Modeling. 2012;52(3):834\u2013843. doi: 10.1021/ci200481c.", "ArticleIdList": ["10.1021/ci200481c", "22332590"]}, {"Citation": "Yamazaki M. The pharmacological studies on matrine and oxymatrine. Yakugaku Zasshi. 2000;120(10):1025\u20131033.", "ArticleIdList": ["11082713"]}, {"Citation": "Donohue J. F. Therapeutic responses in asthma and COPD: bronchodilators. Chest. 2004;126(2, supplement):125S\u2013161S. doi: 10.1378/chest.126.2_suppl_1.125s.", "ArticleIdList": ["10.1378/chest.126.2_suppl_1.125s", "15302773"]}, {"Citation": "Zhang Z. Y., Kaminsky L. S. Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochemical Pharmacology. 1995;50(2):205\u2013211. doi: 10.1016/0006-2952(95)00120-o.", "ArticleIdList": ["10.1016/0006-2952(95)00120-o", "7632164"]}, {"Citation": "Yang K. H., Lee J. H., Lee M. G. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: Involvement of CYP1A1/2 in the formation of 1,3-DMU. Journal of Pharmacy and Pharmacology. 2008;60(1):45\u201353. doi: 10.1211/jpp.60.1.0006.", "ArticleIdList": ["10.1211/jpp.60.1.0006", "18088504"]}, {"Citation": "Ueng Y. F., Tsai C. C., Lo W. S., Yun C. H. Induction of hepatic cytochrome p450s by the herbal medicine sophora flavescens extract in rats: impact on the elimination of theophylline. Drug Metabolism and Pharmacokinetics. 2010;25(6):560\u2013567. doi: 10.2133/dmpk.dmpk-10-rg-055.", "ArticleIdList": ["10.2133/dmpk.dmpk-10-rg-055", "20930420"]}, {"Citation": "Hayashi K., Homma K., Wakino S., et al. T-type Ca channel blockade as a determinant of kidney protection. The Keio Journal of Medicine. 2010;59(3):84\u201395. doi: 10.2302/kjm.59.84.", "ArticleIdList": ["10.2302/kjm.59.84", "20881449"]}, {"Citation": "Chovan J. P., Ring S. C., Yu E., Baldino J. P. Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley rats. Xenobiotica. 2007;37(5):459\u2013473. doi: 10.1080/00498250701245250.", "ArticleIdList": ["10.1080/00498250701245250", "17523050"]}, {"Citation": "Wong A. L., Chan T. Y. Interaction between warfarin and the herbal product Quilinggao . The Annals of Pharmacotherapy. 2003;37(6):836\u2013838. doi: 10.1345/aph.1c503.", "ArticleIdList": ["10.1345/aph.1c503", "12773074"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "9", "Day": "4"}, {"Year": "2014", "Month": "12", "Day": "22"}, {"Year": "2014", "Month": "12", "Day": "27"}, {"Year": "2015", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "9", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "8", "Day": "3"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26339628", "PMC4538340", "10.1155/2015/657159"]}}], "PubmedBookArticle": []}